INmune Bio, Inc. (NASDAQ:INMB) Q2 2023 Earnings Call Transcript August 7, 2023
INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.00036, expectations were $-0.4.
Operator: Greetings, and welcome to the INmune Bio Second Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is my pleasure to introduce to you Mr. David Moss, CFO of INmune Bio. David,...
